Innate Pharma (IPHA) Operating Leases (2017 - 2026)
Innate Pharma's Operating Leases was $1.95 million in the quarter ended Jun 30, 2026, up 55.5% from $1.25 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Operating Leases (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Operating Leases at Innate Pharma came in at $3.93 million.
- Operating Leases shows a five-year compound annual growth rate of 38.5% (years ended Dec 2020 to Dec 2025).
- In earlier years, Operating Leases was $296,561 in the year ended Dec 31, 2024 (-54.5%), $652,276 in the year ended Dec 31, 2023 (-59.9%), $1.63 million in the year ended Dec 31, 2022 (+119.6%) and $740,149 in the year ended Dec 31, 2021 (-4.1%).
- Quarterly Operating Leases has moved between $292,795 (the quarter ended Dec 31, 2024) and $4.05 million (the quarter ended Dec 31, 2025) over five years.
- The best year-over-year quarter for Operating Leases over five years was the quarter ended Jun 30, 2025 (growth of 210.0%); the worst was the quarter ended Jun 30, 2022 (a decline of 87.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Innate Pharma | 159.32 Mn | 159.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.95 Mn |
| Dec 31, 2025 | 4.05 Mn |
| Jun 30, 2025 | 1.25 Mn |
| Dec 31, 2024 | 292,795.14 |
| Jun 30, 2024 | 403,832.84 |
| Dec 31, 2023 | 648,791.77 |
| Jun 30, 2023 | 1.91 Mn |
| Dec 31, 2022 | 1.57 Mn |
| Jun 30, 2022 | 834,438.33 |
| Dec 31, 2021 | 740,149.21 |
| Jun 30, 2021 | 6.77 Mn |
| Dec 31, 2020 | 805,987.94 |
| Jun 30, 2020 | 171,000.00 |
| Dec 31, 2019 | 157,178.05 |
| Dec 31, 2018 | 43,373.06 |
| Dec 31, 2017 | 1.19 Mn |
API Access
Innate Pharma Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();